Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Inventory (2021 - 2023)

Historic Inventory for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $22.7 million.

  • ADC Therapeutics' Inventory rose 4435.06% to $22.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $22.7 million, marking a year-over-year increase of 4435.06%. This contributed to the annual value of $12.1 million for FY2022, which is 10845062.04% up from last year.
  • ADC Therapeutics' Inventory amounted to $22.7 million in Q3 2023, which was up 4435.06% from $19.4 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Inventory high stood at $22.7 million for Q3 2023, and its period low was $7718.0 during Q2 2021.
  • Its 3-year average for Inventory is $11.2 million, with a median of $13.4 million in 2022.
  • As far as peak fluctuations go, ADC Therapeutics' Inventory soared by 19651588.41% in 2022, and later skyrocketed by 3261.43% in 2023.
  • Over the past 3 years, ADC Therapeutics' Inventory (Quarter) stood at $8.7 million in 2021, then surged by 38.15% to $12.1 million in 2022, then surged by 88.25% to $22.7 million in 2023.
  • Its last three reported values are $22.7 million in Q3 2023, $19.4 million for Q2 2023, and $18.2 million during Q1 2023.